Tissue kallikrein for the treatment of pancreatic beta-cell dysfunction
CA2659012A1
Methods of diagnosis and treatment for metabolic disorders
WO2007082381A1
Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders
WO2006079212A1
Use of s-adenosylmethionme, vitamin e, and vitamin c for the treatment of oxidative liver injury or insulin resistance
WO2006063465A1
Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
EP1758597A1
Use of drug combinations for treating insulin resistance
US2007238762A1
Use of Antagonists of Hepatic Sympathetic Nerve Activity
CA2536515A1
Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values
US2004151785A1
Method for treating insulin resistance through hepatic nitric oxide
AU2003201577B2
Use of phosphodiesterase antagonists to treat insulin resistance
AU2003201579B2
Use of glutathione synthesis stimulating compounds in reducing insulin resistance
EP1471905A1
Use of cholinesterase antagonists to treat insulin resistance
EP1126831A1
Method for treating insulin resistance through hepatic nitric oxide
